Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
128M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+381K
-
Total reported value, excl. options
-
$375M
-
Value change
-
+$8.76M
-
Number of buys
-
26
-
Number of sells
-
-20
-
Price
-
$22.11
Significant Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q1 2018
56 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q1 2018.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 128M outstanding shares and own 13.35% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (4.09M shares), Sectoral Asset Management Inc (1.65M shares), Vivo Capital, LLC (1.46M shares), Hillhouse Capital Management, Ltd. (1.43M shares), BlackRock Inc. (1.11M shares), EcoR1 Capital, LLC (1.06M shares), FMR LLC (998K shares), Sofinnova Ventures Inc (912K shares), RA CAPITAL MANAGEMENT, LLC (900K shares), and Clough Capital Partners L P (622K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.